According to the company, the CytoSure™ Next-Generation Sequencing (NGS) Panel will combine the strength of microarrays and NGS to deliver a comprehensive all-in-one assay. The new panel facilitates the accurate detection of loss of heterozygosity mosaicism and copy number variants (CNVs) in addition to single nucleotide variants and indels, and it enables users to detect single-exon CNVs accurately. It was designed to meet the increasing desire of labs to transition from microarrays to NGS and obtain as much information as possible from a single assay.